Search results for "Colorectal cancer"
Antibody-based multitarget FIT may be more accurate than standard FIT
A multitarget fecal immunochemical test (FIT) could reduce colorectal cancer incidence and death and might be cost-effective, according to a recent validation study.
https://gastroenterology.acponline.org/archives/2021/07/23/3.htm
23 Jul 2021
Spotlight on PPIs and cancer
Recent studies assessed the association between proton-pump inhibitors (PPIs) and cancer, as well as the effects of PPI treatment after a cancer diagnosis.
https://gastroenterology.acponline.org/archives/2021/07/23/5.htm
23 Jul 2021
Colorectal cancer risk higher after incomplete polyp resection
A follow-up analysis of patients who had a 5- to 20-mm neoplastic polyp resected found significantly greater risk of advanced neoplasia on their next colonoscopy if the resection was incomplete.
https://gastroenterology.acponline.org/archives/2021/08/27/6.htm
27 Aug 2021
Transportation, patient education among factors affecting colonoscopy rates after abnormal FIT, survey finds
Primary care physicians and staff were asked to identify patients' barriers to completing colonoscopy after an abnormal fecal immunochemical test (FIT) result, as well as factors that made completion more likely.
https://gastroenterology.acponline.org/archives/2021/08/27/2.htm
27 Aug 2021
Low-value cancer screening may be commonly provided to older U.S. adults
An observational study found that patients often continued to be screened for cervical, breast, and colorectal cancer after passing guideline-recommended age thresholds.
https://gastroenterology.acponline.org/archives/2021/08/27/8.htm
27 Aug 2021
Be on alert for CRC in younger patients
A story in the September ACP Internist explained why medical groups are coming to consensus about expanded screening guidelines for colorectal cancer (CRC) that lower the age to begin screening.
https://gastroenterology.acponline.org/archives/2021/09/24/6.htm
24 Sep 2021
Spotlight on COVID-19 and GI cancers
Recent international studies found that the COVID-19 pandemic may be associated with fewer new diagnoses of gastric cancer and colorectal cancer (CRC), as well as increased tumor burden in patients with newly diagnosed metastatic CRC.
https://gastroenterology.acponline.org/archives/2021/09/24/5.htm
24 Sep 2021
Guidance offered for managing colorectal dysplasia in patients with IBD
Among other best practice advice from the American Gastroenterological Association, precancerous colorectal lesions in patients with inflammatory bowel disease (IBD) should be described as polypoid, nonpolypoid, or invisible using a modified Paris Classification.
https://gastroenterology.acponline.org/archives/2021/09/24/1.htm
24 Sep 2021
Flexible sigmoidoscopy associated with long-term reduction in colorectal cancer incidence, mortality
Colorectal cancer incidence and mortality were reduced by about 20% in patients who were randomized to receive once-only flexible sigmoidoscopy screening between the ages of 55 to 64 years instead of usual care.
https://gastroenterology.acponline.org/archives/2021/11/19/6.htm
19 Nov 2021
Guideline from CRC task force recommends starting screening at ages 45 to 49 years in all average-risk patients
Increasing disease incidence and a favorable harm-benefit ratio are two reasons to expand the age range for colorectal cancer (CRC) screening to younger patients, a task force determined.
https://gastroenterology.acponline.org/archives/2021/11/19/1.htm
19 Nov 2021